CUMYL-CBMINACA (SGT-277) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first being identified in Germany in February 2020. It is illegal in Finland.

See also CUMYL-3TMS-PRINACA CUMYL-CBMICA CUMYL-CH-MEGACLONE CUMYL-CHMICA CUMYL-THPINACA

References